7alpha-dehydroxylation of cholic acid and chenodeoxycholic acid by bai operon genes (Mus musculus)

From WikiPathways

Revision as of 13:53, 24 December 2025 by Jmrodriguezc (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search


Description

This pathway summarizes the gut bacterial 7α dehydroxylation of unconjugated primary bile acids, in which deconjugated cholic acid (CA) and chenodeoxycholic acid (CDCA) are converted to the secondary bile acids deoxycholic acid (DCA) and lithocholic acid (LCA), respectively, by Firmicutes such as Clostridium and related genera that carry bile acid–inducible (bai) genes.

It follows a multi-step bai operon–dependent route in which bile acids are transported into the cell and transformed through CoA thioester formation, sequential oxidations, a 7α dehydration step and subsequent reductions and CoA removal, highlighting the central roles of BaiB, BaiA2, BaiCD, BaiE, BaiF, BaiH and BaiN. Because no single consensus mechanism is fully established, the pathway explicitly shows the two main proposed enzyme orders derived from recent in vitro and in vivo work. The model highlighted in green, emphasizes an oxidative–reductive sequence in which BaiH catalyses the first reductive step, while BaiCD and BaiA2 act twice, at the beginning and the end of the redox cascade:

BaiB → BaiA2 → BaiCD → BaiE → BaiF → BaiH → BaiCD → BaiA2

An alternative model (highlighted in purple) supported by other reconstitution and review studies, proposes the sequence:

BaiB → BaiA2 → BaiCD → BaiF → BaiE → BaiN → BaiN → BaiA2

In addition, downstream of LCA formation, the diagram shows, highlighted in light blue, microbiota derived LCA by-products such as 3 oxoLCA, isoLCA, 3 oxoalloLCA, alloLCA and isoalloLCA, which are now established in human stool and are produced by combinations of bai encoded enzymes together with additional 5α/5β reductases and 3α/3β HSDHs encoded in distinct gene clusters; for these branches, the overall existence of the metabolites and enzyme activities is well supported, whereas the exact sequence of intermediates remains partially reconstructed.

The diagram therefore captures the shared intermediates and directionality of 7α dehydroxylation, while indicating that the exact order and division of labor among bai and non bai enzymes, and their strain specific variants, remain active areas of research.



>> Metabolite and enzyme abbreviations used with their full common names:

  • CA: Cholic acid
  • CA-CoA: Cholyl-coenzyme A
  • 3-oxoCA-CoA: 3-oxo-Cholic acid-coenzyme A
  • 3-oxoΔ4-CA-CoA: 3-oxo-delta4-cholyl-coenzyme A
  • 3-oxoΔ4-CA: 3-oxo-delta4-Cholic acid
  • 3-oxoΔ4,6-DCA: 3-oxo-delta4,6-Deoxycholic acid
  • 3-oxoΔ4-DCA: 3-oxo-delta4-Deoxycholic acid
  • 3-oxoDCA: 3-oxo-Deoxycholic acid
  • DCA: Deoxycholic acid
  • IsoDCA: Isodeoxycholic acid
  • CDCA: Chenodeoxycholic Acid
  • CDCA-CoA: Chenodeoxycholoyl-coenzyme A
  • 3-oxoCDCA-CoA: 3-oxo-chenodeoxycholyl-coenzyme A
  • 3-oxoΔ4-CDCA-CoA: 3-Oxo-delta4-chenodeoxycholyl-coenzyme A
  • 3-oxoΔ4-CDCA: 3-Oxo-4-cholenoic acid
  • 3-oxoΔ4,6-LCA: 3-Oxo-4,6-choladienoic acid
  • 3-oxoΔ4-LCA: 3-Oxo-4-cholenic acid
  • 3-oxoLCA: Dehydrolithocholic Acid
  • LCA: Lithocholic acid
  • IsoLCA: Isolithocholic acid
  • 3-oxoalloLCA: 3-Oxoallolithocholic acid
  • isoalloLCA: Isoallolithocholic acid
  • alloLCA: Allolithocholic acid
  • BAIB_CLOSV: Bile acid-coenzyme A ligase, Clostridium scindens
  • BAIA1_CLOSV: 3alpha-hydroxy bile acid-coenzyme A-ester 3-dehydrogenase, Clostridium scindens
  • BAICD_CLOSV: 3-oxocholoyl-coenzyme A 4-desaturase, Clostridium scindens
  • BAIF_CLOSV: Bile acid coenzyme A-transferase BaiF, Clostridium scindens
  • BAIE_CLOSV: Bile acid 7alpha-dehydratase, Clostridium scindens
  • BAIN_CLOS5: 3-dehydro-bile acid delta(4,6)-reductase, Clostridium scindens
  • BAIA2_CLOSV: 3alpha-hydroxy bile acid-coenzyme A-ester 3-dehydrogenase 2, Clostridium scindens
  • BAIH_CLOSV: 7-beta-hydroxy-3-oxochol-24-oyl-coenzyme A 4-desaturase, Clostridium scindens
  • 3AHDP_MEDG7: 3alpha-hydroxysteroid dehydrogenase, Mediterraneibacter gnavus
  • 3AHD_EGGLE: 3alpha-hydroxysteroid dehydrogenase, Eggerthella lenta
  • 3BHDP_MEDG7: 3beta-hydroxysteroid dehydrogenase, Mediterraneibacter gnavus
  • 3BHD2_EGGLE: 3beta-hydroxysteroid dehydrogenase 2, Eggerthella lenta
  • 5AR: 5alpha-reductase

Please use the New WikiPathways

View approved pathways at the new wikipathways.org. This website will shutdown soon.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD; ''Bile acid metabolism and signaling, the microbiota, and metabolic disease.''; Pharmacol Ther, 2022 PubMed Europe PMC Scholia
  2. Sato Y, Atarashi K, Plichta DR, Arai Y, Sasajima S, Kearney SM, Suda W, Takeshita K, Sasaki T, Okamoto S, Skelly AN, Okamura Y, Vlamakis H, Li Y, Tanoue T, Takei H, Nittono H, Narushima S, Irie J, Itoh H, Moriya K, Sugiura Y, Suematsu M, Moritoki N, Shibata S, Littman DR, Fischbach MA, Uwamino Y, Inoue T, Honda A, Hattori M, Murai T, Xavier RJ, Hirose N, Honda K; ''Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians.''; Nature, 2021 PubMed Europe PMC Scholia
  3. Kim KH, Park D, Jia B, Baek JH, Hahn Y, Jeon CO; ''Identification and Characterization of Major Bile Acid 7α-Dehydroxylating Bacteria in the Human Gut.''; mSystems, 2022 PubMed Europe PMC Scholia
  4. Lee JW, Cowley ES, Wolf PG, Doden HL, Murai T, Caicedo KYO, Ly LK, Sun F, Takei H, Nittono H, Daniel SL, Cann I, Gaskins HR, Anantharaman K, Alves JMP, Ridlon JM; ''Formation of secondary allo-bile acids by novel enzymes from gut Firmicutes.''; Gut Microbes, 2022 PubMed Europe PMC Scholia
  5. Ridlon JM, Kang DJ, Hylemon PB; ''Bile salt biotransformations by human intestinal bacteria.''; J Lipid Res, 2006 PubMed Europe PMC Scholia
  6. Wise JL, Cummings BP; ''The 7-α-dehydroxylation pathway: An integral component of gut bacterial bile acid metabolism and potential therapeutic target.''; Front Microbiol, 2022 PubMed Europe PMC Scholia
  7. Guzior DV, Quinn RA; ''Review: microbial transformations of human bile acids.''; Microbiome, 2021 PubMed Europe PMC Scholia
  8. Devlin AS, Fischbach MA; ''A biosynthetic pathway for a prominent class of microbiota-derived bile acids.''; Nat Chem Biol, 2015 PubMed Europe PMC Scholia
  9. Fleishman JS, Kumar S; ''Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.''; Signal Transduct Target Ther, 2024 PubMed Europe PMC Scholia
  10. Ma H, Wang K, Jiang C; ''Microbiota-derived bile acid metabolic enzymes and their impacts on host health.''; Cell Insight, 2025 PubMed Europe PMC Scholia
  11. Funabashi M, Grove TL, Wang M, Varma Y, McFadden ME, Brown LC, Guo C, Higginbottom S, Almo SC, Fischbach MA; ''A metabolic pathway for bile acid dehydroxylation by the gut microbiome.''; Nature, 2020 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
142267view17:16, 24 December 2025JmrodriguezcOntology Term : 'primary bile acid biosynthetic pathway' added !
142266view17:16, 24 December 2025JmrodriguezcOntology Term : 'bile acid biosynthetic pathway' added !
142265view17:15, 24 December 2025JmrodriguezcOntology Term : 'secondary bile acid biosynthetic pathway' added !
142258view14:01, 24 December 2025JmrodriguezcCNIC-M/Exxx names fixed to correct formatting.
142257view13:53, 24 December 2025JmrodriguezcNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
3-oxoCA-CoAMetaboliteLMST04010457 (LIPID MAPS)
3-oxoCDCA-CoAMetaboliteCNIC-M001 (nan)
3-oxoDCAMetaboliteLMST04010168 (LIPID MAPS)
3-oxoLCAMetaboliteLMST04010127 (LIPID MAPS)
3-oxoalloLCAMetaboliteLMST04010128 (LIPID MAPS)
3-oxoΔ4,6-DCAMetaboliteLMST04010245 (LIPID MAPS)
3-oxoΔ4,6-LCAMetaboliteLMST04010235 (LIPID MAPS)
3-oxoΔ4-CA-CoAMetabolite121596241 (PubChem-compound)
3-oxoΔ4-CAMetaboliteLMST04010241 (LIPID MAPS)
3-oxoΔ4-CDCA-CoAMetaboliteLMST04010462 (LIPID MAPS)
3-oxoΔ4-CDCAMetaboliteLMST04010239 (LIPID MAPS)
3-oxoΔ4-DCAMetaboliteLMST04010240 (LIPID MAPS)
3-oxoΔ4-LCAMetaboliteLMST04010233 (LIPID MAPS)
3AHDP_MEDG7GeneProductA7B3K3 (Uniprot-TrEMBL)
3AHD_EGGLEGeneProductC8WMP0 (Uniprot-TrEMBL)
3BHD2_EGGLEGeneProductC8WGQ3 (Uniprot-TrEMBL)
3BHDP_MEDG7GeneProductA7AZH2 (Uniprot-TrEMBL)
5ARGeneProductCNIC-E001 (nan)
BAIA2_CLOSVGeneProductP19337 (Uniprot-TrEMBL)
BAIB_CLOSVGeneProductP19409 (Uniprot-TrEMBL)
BAICD_CLOSVGeneProductP19410 (Uniprot-TrEMBL)
BAIE_CLOSVGeneProductP19412 (Uniprot-TrEMBL)
BAIF_CLOSVGeneProductP19413 (Uniprot-TrEMBL)
BAIH_CLOSVGeneProductP32370 (Uniprot-TrEMBL)
BAIN_CLOS5GeneProductB0NAQ4 (Uniprot-TrEMBL)
CA-CoAMetabolite644071 (PubChem-compound)
CAMetaboliteLMST04010001 (LIPID MAPS)
CDCA-CoAMetabolite11966205 (PubChem-compound)
CDCAMetaboliteLMST04010032 (LIPID MAPS)
DCAMetaboliteLMST04010040 (LIPID MAPS)
IsoDCAMetaboliteLMST04010042 (LIPID MAPS)
IsoLCAMetaboliteLMST04010004 (LIPID MAPS)
LCAMetaboliteLMST04010003 (LIPID MAPS)
alloLCAMetaboliteLMST04010005 (LIPID MAPS)
isoalloLCAMetaboliteLMST04010006 (LIPID MAPS)

Annotated Interactions

No annotated interactions

Personal tools